Recently introduced laws surrounding prescription requirements for codeine medication have lead to a significant reduction in the manufacture of low-dose products.
Panadeine was Australia’s leading codeine-based painkiller until legal restrictions ceased its’ production, leaving many reliant individuals seeking illegal alternatives.
The tightened legislation comes in response to data detailing 300 annual deaths from prescription drug overdoses, and are a gradual attempting to wean patients off the substance.